| ?? |
?? ?? |
CAS |
MF |
 |
4'-(pyrimidin-2-ylsulphamoyl)acetanilide |
127-74-2 |
C12H12N4O3S |
 |
LevetiracetaM IMpurity B |
358629-47-7 |
C8H12N2O2 |
 |
LEVOCARNITINE RELATED COMPOUND A (100 MG) (3-CARBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE) |
6538-82-5 |
C7H13ClNO2 |
 |
Cetirizine Ethyl Ester (USP RC A) |
246870-46-2 |
C23H29ClN2O3 |
 |
1-Cyano-3-isopropylguanidine |
44830-55-9 |
C5H10N4 |
 |
?????? |
68525-86-0 |
|
 |
?????(????????) |
878143-33-0 |
C20H24N2O6S |
|
|
Boric acid (isotope ratio) |
|
|
 |
Iron-56Fe solution |
|
Fe |
|
|
CALCIUM ASCORBATE - REFERENCE SPECTRUM |
|
|
 |
Ranitidine Resolution Mixture |
|
C13H22N4O3S |
 |
Chloroquine Related CoMpound E |
5428-61-5 |
C18H26ClN3 |
 |
Copper-65Cu solution |
|
Cu |
|
|
FLUMAZENIL - REFERENCE SPECTRUM |
|
|
|
|
HEPARIN LOW-MOLECULAR-MASS FOR CALIBRATION CRS |
|
|
|
|
Abacavir StereoisoMers Mixture |
|
|
|
|
Hemoglobin HbA0 (non-glycated) |
|
|
|
|
Vitamin D Assay System Suitability |
|
|
|
|
Megestrol Acetate IMpurity K |
|
|
|
|
MeloxicaM Related CoMpound D |
|
|
 |
CHLORAMPHENICOL DISODIUM DISUCCINATE |
|
C19H20Cl2N2Na2O13-2 |
![3-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-alpha,alpha-diMethyl benzeneacetic acid hydrochloride](/CAS/20200119/GIF/CB12541748.gif) |
3-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-alpha,alpha-diMethyl benzeneacetic acid hydrochloride |
|
C32H40ClNO4 |
|
|
EUROSOIL 5 |
|
|
 |
OXOLINIC ACID IMPURITY A |
26893-27-6 |
C11H7NO5 |
|
|
CLOSANTEL SODIUM DIHYDRATE |
|
|
-6-cyano-1(3H)-isobenzofuranone oxalate](/CAS/20200119/GIF/CB32541601.gif) |
3-[3-(diMethylaMino)-1-propyl](4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
|
C22H21FN2O6 |
|
|
Anastrozole iMpurity E |
|
|
|
|
CitalopraM Related CoMpound G |
|
|
|
|
Levothyroxine for Peak Identification |
|
|
|
|
Orlistat Related CoMpound E |
|
|
|
|
EUROSOIL 1 |
|
|
|
|
Pharmaceutical glass containers (Alkali leaching and release) |
|
|
|
|
Lithium carbonate-7Li |
|
7Li2CO3 |
![Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione)](/CAS/20200515/GIF/160596-25-8.gif) |
Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione) |
160596-25-8 |
C18H17N3O3S |
|
|
DIPHENOXYLATE HYDROCHLORIDE - REFERENCE SPECTRUM |
|
|
 |
TIAPRIDE N-OXIDE |
63484-11-7 |
C15H24N2O5S |
|
|
ACECLOFENAC - REFERENCE SPECTRUM |
|
|
|
|
POLYGLYCERYL-3 DIISOSTEARATE |
66082-42-6 |
C45H88O9 |
|
|
Silicon (isotope ratio) |
|
|
 |
Triprolidine Hydrochloride Z-IsoMer |
51657-91-1 |
C19H23ClN2 |
|
|
RETINOL ESTERS |
|
|
|
|
OXFENDAZOLE WITH IMPURITY D |
|
|
 |
Boron-11B solution |
|
BH3 |
|
|
Platinum (isotope ratio) |
|
|
|
|
Pyrantel Related CoMpound A |
|
|
 |
ALLOPURINOL IMPURITY A |
|
C5H4N4O |
|
|
Vancomycin B with Monodechlorovancomycin |
|
|
 |
TICARCILLIN IMPURITY A |
6933-26-2 |
C13H12OS |
|
|
TYLOSIN PHOSPHATE FOR PEAK IDENTIFICATION |
|
|
 |
Cefoperazone dihydrate |
113826-44-1 |
C25H29N9O9S2 |
 |
?????????G(15-mg)(7-???-1,4-???-5-??-4,5-????-1H-1,4-??????-2,3-??) |
93329-92-1 |
C17H15ClN2O2 |
 |
Flutrimazole carbinol |
128092-72-8 |
C19H14F2O |
|
|
HYDROUS BENZOYL PEROXIDE - REFERENCE SPECTRUM |
|
|
 |
82999, 237NpO2 (V encapsulated) |
58670-16-9 |
NpO2 |
|
|
Medroxyprogesterone Acetate Related CoMpound A |
|
|
|
|
EUROSOIL 2 |
|
|
|
|
AMIODARONE IMPURITY D |
|
|
 |
DIPHENHYDRAMINE IMPURITY A |
|
C17H21NO |
|
|
TRANS-EPOXYPHYTOMENADIONE |
|
|
 |
70476-82-3 |
70476-82-3 |
|
|
|
Cefprozil Related CoMpound K |
|
|
|
|
PROPACETAMOL HYDROCHLORIDE - REFERENCE SPECTRUM |
|
|
 |
Abacavir Related CoMpound D |
1443421-69-9 |
C18H21ClN10O |
|
|
Enrofloxacin Related CoMpound Mixture |
|
|
|
|
DICLAZURIL FOR VETERINARY USE - REFERENCE SPECTRUM |
|
|
|
|
TRICLOSAN RELATED COMPOUNDS MIXTURE A (1.2 ML/AMPULE; 3 AMPULES) |
|
|
 |
picotamide monohydrate |
80530-63-8 |
|
|
|
EUROSOIL 4 |
|
|
|
|
Human serum (high creatinine) |
|
|
 |
Fluticasone Propionate Resolution Mixture |
|
C28H35F3O6S |
 |
96946-42-8 |
96946-42-8 |
|
 |
Cadmium-111Cd solution |
|
Cd |
 |
OseltaMivir IMpurity A |
1364932-19-3 |
C14H24N2O4 |
|
|
LaMivudine Resolution Mixture C |
|
|
 |
METHYLTHIONINIUM IMPURITY A |
1231958-32-9 |
C16H18N3S+ |
 |
1-(3,4-dichlorophenyl)-5-isopropylbiguanide monohydrochloride |
6001-93-0 |
C11H16Cl3N5 |
 |
SalMeterol Resolution Check |
|
C25H37NO4 |
 |
IFOSFAMIDE IMPURITY E |
42453-19-0 |
C5H11Cl2N |
|
|
PANCREAS POWDER (PROTEASE) BRP |
|
|
|
|
GENOMIC DNA OF ESCHERICHIA COLI O157 (EDL 933) |
|
|
|
|
GMO Standard ERM-BF411, Maize Bt-176 |
|
|
 |
Temazepam Related Compound F (15 mg) (7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione) |
3294-96-0 |
C16H13ClN2O2 |
|
|
EUROSOIL 3 |
|
|
|
|
CeftazidiMe, Delta-3-IsoMer |
|
|
|
|
Fosinopril Related CoMpound F |
|
|
|
|
OMeprazole Related CoMpound F and G Mixture |
|
|
 |
SulfaMethoxazole Related CoMpound F |
17103-52-5 |
C10H11N3O3S |
 |
IFOSFAMIDE IMPURITY B |
241482-18-8 |
C10H24Cl2N2O7P2 |
|
|
Lamivudine Resolution Mixture B |
|
|
 |
137234-62-9 |
137234-62-9 |
C16H14F3N5O |
 |
Rubidium-85Rb solution |
|
Rb |
 |
Cefadroxil Related CoMpound I |
147103-94-4 |
C16H17N3O5S |
|
|
Cefprozil Related CoMpound H |
|
|
|
|
TRIMETHOPRIM IMPURITY B |
|
|
|
|
GMO Standard ERM-BF412, Maize Bt-11 |
|
|
 |
(S)-1-(3-((ethyl(methyl)carbamoyl)oxy)phenyl)-N,N-dimethylethanamine |
415973-05-6 |
C14H22N2O2 |
|
|
MetaMizole iMpurity E |
|
|
|
|
GalantaMine HydrobroMide Related CoMpounds Mixture |
|
|
|
|
ENDOTOXIN STANDARD |
|
|
|
|
POTASSIUM CLAVULANATE - REFERENCE SPECTRUM |
|
|